TEM

Tempus AI Inc

66.86

Aug 24 • 3:41 PM ET -5.83 (-8.01%)

Healthcare Health Information Services USA Large NASD

Today, 8:45 AMTempus AI receives FDA 510(k) clearance for ECG-PH software detecting pulmonary hypertension from standard 12-lead ECGs

Peers: VEEV DOCS AI EVH PHR HCAT PLTR TDOC BBAI DH

| Held by: ARKE ARKK ARKG VTI VB VBK IBB JTEK VXF IWP

Scroll to Statements

Index	-
Market Cap	12.06B
Enterprise Value	12.69B
Income	-254.43M
Sales	1.43B
Book/sh	2.47
Cash/sh	4.52
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	3800
IPO	Jun 14, 2024

P/E	-
Forward P/E	2365.23
PEG	-
P/S	8.42
P/B	27.06
P/C	14.79
P/FCF	-
EV/EBITDA	-
EV/Sales	8.86
Quick Ratio	3.16
Current Ratio	3.30
Debt/Eq	3.25
LT Debt/Eq	3.22
Option/Short	Yes / Yes

EPS (ttm)	-1.44
EPS next Y	0.03
EPS next Q	-0.07
EPS this Y	65.57%
EPS next Y	113.46%
EPS next 5Y	-
EPS past 3/5Y	10.57% 1.21%
Sales past 3/5Y	58.29% 46.57%
EPS Y/Y TTM	-21.05%
Sales Y/Y TTM	50.43%
EPS Q/Q	112.51%
Sales Q/Q	21.56%
Earnings	Jul 30 AMC
EPS/Sales Surpr.	71.99% 0.74%

Insider Own	40.59%
Insider Trans	-1.83%
Inst Own	55.83%
Inst Trans	4.50%
ROA	-12.75%
ROE	-67.44%
ROIC	-13.56%
Gross Margin	62.92%
Oper. Margin	-18.92%
Profit Margin	-17.77%
SMA20	27.27%
SMA50	26.15%
SMA200	17.95%
Trades

Shs Outstand	175.02M
Shs Float	107.19M
Short Float	31.00%
Short Ratio	5.04
Short Interest	33.23M
52W High	104.32 -35.90%
52W Low	40.77 64.01%
Volatility	8.91% 7.36%
ATR (14)	4.55
RSI (14)	64.99
Beta	3.78
Rel Volume	1.38
Avg Volume	6.59M
Volume	8,687,153

Perf Week	29.48%
Perf Month	56.63%
Perf Quarter	44.79%
Perf Half Y	16.71%
Perf YTD	13.23%
Perf Year	-16.96%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	2.32
Target Price	62.79
Prev Close	72.69
Price	66.86
Change %	-8.01%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-02-26	Resumed	Wolfe Research	Peer Perform
Apr-13-26	Upgrade	TD Cowen	Hold → Buy	$65
Apr-13-26	Initiated	Jefferies	Underperform	$35
Feb-19-26	Initiated	Mizuho	Outperform	$100
Feb-17-26	Initiated	Robert W. Baird	Outperform	$59
Dec-02-25	Resumed	Morgan Stanley	Overweight	$85
Oct-21-25	Downgrade	TD Cowen	Buy → Hold	$88
Oct-20-25	Initiated	Canaccord Genuity	Buy	$110
Sep-02-25	Initiated	H.C. Wainwright	Buy	$90
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50

Show Previous Ratings

Today 02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis) -8.01%
08:30AM	Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs (Business Wire)
Aug-20-26 01:22PM	TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight (Stocktwits) +8.82%
Aug-19-26 01:49PM	TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial (Stocktwits) +24.09%
Aug-06-26 09:15AM	CellCarta Adds Tempus to CDx Commercialization Lab Network (PR Newswire)
08:30AM	Loading…
Aug-04-26 08:30AM	Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications (Business Wire)
Jul-31-26 01:12PM	Beyond Mega IPOs: ICR Capital President & Chairman Don Duffy, Live from NYSE (IPO-Edge.com)
01:02AM	Tempus AI Inc (TEM) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% to $382. ... (GuruFocus.com)
Jul-30-26 04:14PM	Tempus: Q2 Earnings Snapshot (Associated Press) +6.59%
04:01PM	Tempus Reports Second Quarter 2026 Results (Business Wire)
Jul-24-26 09:10AM	A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed (PR Newswire) -7.22%
07:30AM	Cathie Wood's Ark Bought the Dip in Tesla Stock (Barrons.com)
Jul-22-26 08:30AM	Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine (Business Wire)
Jul-21-26 08:40AM	Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal (Quartz)
08:30AM	Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion (Quartz)
07:43AM	Loading…
07:43AM	Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal (Medical Device Network)
Jul-20-26 04:56PM	Tempus AI Buys Personalis in $1.7 Billion Precision Oncology Deal (GuruFocus.com) -7.74%
03:38PM	TEM, PSNL Stocks Are Falling Why Morgan Stanley Still Likes Tempus AIs Personalis Deal (Stocktwits)
11:31AM	Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive (Investor's Business Daily)
11:23AM	Tempus AI to acquire cancer-monitoring firm Personalis for $1.5B (Proactive)
11:11AM	TEMs Deal To Acquire PSNL Opens Door For $20B Cancer Market Opportunity Retail Awaits To See Execution (Stocktwits)
10:44AM	Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink (Barrons.com)
10:38AM	Tempus to buy cancer test-maker Personalis for $1.5B (MedTech Dive)
08:35AM	Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform (Business Wire)
Jul-17-26 09:42AM	Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies. (Investor's Business Daily)
Jul-09-26 09:00AM	Tempus to Report Second Quarter 2026 Financial Results on July 30 (Business Wire) +7.39%
Jul-02-26 06:41PM	CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology (Exec Edge)
Jul-01-26 10:46PM	TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' Story (Stocktwits) +6.34%
08:00PM	5 Under-the-Radar Stocks Fueling the AI Revolution (Oilprice.com)
09:04AM	Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX (GuruFocus.com)
09:00AM	Loading…
09:00AM	As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data (PR Newswire)
Jun-25-26 08:30AM	Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers (Business Wire) +5.64%
Jun-16-26 09:11AM	16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap (PR Newswire)
Jun-11-26 08:30AM	Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm (Business Wire)
Jun-09-26 06:00AM	Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal RNA Testing Can Improve Diagnostic Clarity in Exome Testing (Business Wire)
Jun-05-26 04:01PM	Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference (Business Wire) -11.16%
Jun-03-26 08:30AM	Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members (Business Wire)
Jun-01-26 08:30AM	Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH (Business Wire)
May-31-26 08:30AM	Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development (Business Wire)
May-30-26 08:30AM	Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community (Business Wire)
08:00AM	Tempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results (Business Wire)
May-29-26 09:15AM	Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology (Business Wire)
08:15AM	Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio (Business Wire)
May-28-26 08:30AM	Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology (Business Wire) +8.73%
May-27-26 08:33AM	Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows (Business Wire)
May-26-26 08:30AM	Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting (Business Wire)
May-20-26 02:19PM	4 Heavily Shorted AI Stocks to Watch Right Now (Schaeffer's Research)
May-19-26 08:55AM	Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts (PR Newswire)
May-14-26 06:15PM	Imvivas CTA313 Lupus Drug Shows Promising Remission Results (Exec Edge)
08:30AM	Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience (Business Wire)
May-11-26 06:00AM	Ambry Genetics' CARE Program Wins 2026 MedTech Breakthrough Award for "Best Overall Health Informatics Solution" (Business Wire)
May-08-26 12:59AM	Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes (Business Wire)
May-07-26 07:11AM	Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense (Business Wire) -7.53%
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
May-05-26 08:21PM	Tempus AI, Inc. Q1 2026 Earnings Call Summary (Moby)
04:01PM	Tempus Reports First Quarter 2026 Results (Business Wire)
Apr-29-26 08:30AM	Tempus to Host Inaugural Investor Day on May 29, 2026 (Business Wire)
Apr-28-26 08:30AM	Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 (Business Wire)
Apr-23-26 08:30AM	Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine (Business Wire) -7.33%
Apr-21-26 08:30AM	Tempus to Report First Quarter 2026 Financial Results on May 5 (Business Wire)
Apr-15-26 08:30AM	Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring (Business Wire) +13.89%
Apr-14-26 08:30AM	Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026 (Business Wire) +7.72%
Apr-13-26 09:58AM	Nike downgraded, Starbucks upgraded: Wall Street's top analyst calls (The Fly) +7.08%
08:30AM	Tempus Launches Automated "Active Follow-Up" Service to Support Guideline-Concordant Care (Business Wire)
Apr-09-26 08:30AM	Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE (Business Wire) -7.03%
Apr-08-26 04:01PM	Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-26-26 08:57AM	Cathie Wood's Ark Dumped More Meta Stock-and Loaded Up on Another AI Stock Instead (Barrons.com)
06:34AM	Daiichi Sankyo and Tempus AI collaborate on ADC clinical development (Pharmaceutical Business Review)
04:36AM	Meta Stock Dumped by Cathie Wood. Her ARK Funds Go Big On This AI Play Instead. (Barrons.com)
Mar-24-26 03:01PM	Tongcheng Travel Holdings Ltd (FRA:TEM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Mar-17-26 08:30AM	Tempus and Blood Cancer United Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries (Business Wire)
Mar-11-26 08:30AM	Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings (Business Wire)
Mar-10-26 01:33PM	Hims and Hers Expands Consumer-Focused Digital Health Platform (Zacks)
Mar-09-26 08:52AM	Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? (Zacks)
Mar-07-26 07:11AM	Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine (Insider Monkey)
Mar-05-26 08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 06:00PM	Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? (Insider Monkey)
Mar-03-26 02:33PM	AI-Powered Tempus Inks New Multi-Year Merck Deal (Benzinga)
12:19PM	Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes (PR Newswire)
08:30AM	Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine (Business Wire)
Mar-01-26 08:00AM	Consumer Tech News (Feb 23-27): US-Taiwan Trade Tensions Escalates, Amazon Invests $12B In US & More (Benzinga)
Feb-26-26 10:48AM	TEM vs. ILMN: Which MedTech Stock Offers Greater Upside? (Zacks)
08:30AM	Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference (Business Wire)
Feb-25-26 09:20PM	Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million (Benzinga) -7.32%
09:44AM	Tempus AI Posts 83% Revenue Growth Yet Stumbles on Full Year Profitability Target (24/7 Wall St.)
08:30AM	Tempus AI, Inc. Q4 2025 Earnings Call Summary (Moby)
07:26AM	TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market (Zacks)
01:07AM	Tempus AI Q4 Earnings Call Highlights (MarketBeat)
12:02AM	Tempus AI Inc (TEM) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... (GuruFocus.com)
Feb-24-26 08:19PM	AMD, Zeta Global, MercadoLibre, Tempus AI And Workday: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
07:30PM	Tempus AI (TEM) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
05:32PM	Tempus AI Stock Drops Despite Q4 Earnings Beat: Details (Benzinga)
04:01PM	Tempus Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-23-26 10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
07:46AM	AppLovin Surges 11% While Tempus AI and Micron Also Outpace Most AI Stocks (24/7 Wall St.)
07:21AM	Here's How Tempus AI Is Tapping the Imagining Space (Zacks)
Feb-22-26 08:30AM	Consumer Tech News (Feb 16-20): Big Techs To Boost AI in India, EV Policy Shifts & More (Benzinga)
Feb-20-26 10:55AM	Hims & Hers Accelerates AI Preventive Care and Platform Strategy (Zacks)
09:04AM	AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech (Zacks)
Feb-19-26 03:19PM	2 Tech Bets Cathie Wood is Quietly Trimming Right Now: Should You Too? (Barchart) +6.77%

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Co-FounderMr. Eric P. Lefkofsky J.D.

Chief Financial OfficerMr. James Rogers

Executive VP and Chief Administrative & Legal OfficerMr. Erik Phelps

Chief Legal OfficerMr. Andrew Polovin

Chief Executive Officer of Data & AppsMr. Ryan Fukushima

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
VANESSA KUBO	Officer	Aug 21 '26	Proposed Sale	66.65	14,286	952,162		Aug 21 04:34 PM
THOMAS SCHOENHERR	Officer	Aug 21 '26	Proposed Sale	66.65	2,694	179,555		Aug 21 04:33 PM
Fukushima Ryan	CEO, Data	Aug 18 '26	Sale	49.61	41,095	2,038,723	562,463	Aug 20 09:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 18 '26	Sale	49.61	132,591	6,577,840	2,098,130	Aug 20 09:00 PM
Schoenherr Thomas Edward	CEO, Diagnostics	Aug 19 '26	Sale	58.40	8,082	471,991	89,715	Aug 20 09:00 PM
Schoenherr Thomas Edward	CEO, Diagnostics	Aug 18 '26	Sale	49.61	9,232	458,000	97,797	Aug 20 09:00 PM
Rogers James William	Chief Financial Officer	Aug 19 '26	Sale	60.00	26,313	1,578,780	106,024	Aug 20 09:00 PM
Rogers James William	Chief Financial Officer	Aug 18 '26	Sale	49.61	22,529	1,117,664	132,337	Aug 20 09:00 PM
Polovin Andrew	EVP, Chief Legal Officer	Aug 18 '26	Sale	49.61	22,148	1,098,762	146,067	Aug 20 09:00 PM
Polovin Andrew	EVP, Chief Legal Officer	Aug 19 '26	Sale	56.00	7,927	443,912	138,140	Aug 20 09:00 PM
Bartolucci Ryan M	Chief Accounting Officer	Aug 18 '26	Sale	49.61	6,175	306,342	67,866	Aug 20 09:00 PM
Eric Paul Lefkofsky	Officer	Aug 18 '26	Proposed Sale	51.64	132,591	6,846,999		Aug 19 05:03 PM
Andrew Polovin	Officer	Aug 18 '26	Proposed Sale	51.64	22,148	1,143,723		Aug 19 05:02 PM
Ryan Fukushima	Officer	Aug 18 '26	Proposed Sale	51.64	41,095	2,122,146		Aug 19 05:01 PM
Ryan M. Bartolucci	Officer	Aug 18 '26	Proposed Sale	51.64	6,175	318,877		Aug 19 04:59 PM
James William Rogers	Officer	Aug 18 '26	Proposed Sale	51.64	22,529	1,163,398		Aug 19 04:58 PM
Thomas Edward Schoenherr	Officer	Aug 18 '26	Proposed Sale	51.64	9,232	476,740		Aug 19 04:56 PM
JAMES ROGERS	Officer	Aug 19 '26	Proposed Sale	49.36	26,313	1,298,810		Aug 19 04:38 PM
ANDREW POLOVIN	Officer	Aug 19 '26	Proposed Sale	49.36	7,927	391,277		Aug 19 04:32 PM
THOMAS SCHOENHERR	Officer	Aug 19 '26	Proposed Sale	49.36	8,082	398,928		Aug 19 04:31 PM
West Nadja	Director	Aug 14 '26	Sale	53.90	3,000	161,700	34,981	Aug 18 04:15 PM
NADJA WEST	Director	Aug 14 '26	Proposed Sale	54.29	6,000	325,740		Aug 14 04:42 PM
Fukushima Ryan	CEO, Data	Aug 07 '26	Sale	50.04	20,000	1,000,800	123,945	Aug 11 05:29 PM
VANESSA KUBO	Officer	Aug 07 '26	Proposed Sale	46.12	20,000	922,400		Aug 07 04:36 PM
Epstein David R	Director	Aug 03 '26	Sale	43.40	370	16,058	31,094	Aug 05 04:30 PM
Fukushima Ryan	CEO, Data	Aug 03 '26	Sale	46.19	23,818	1,100,076	143,945	Aug 05 04:30 PM
DAVID R. EPSTEIN	Director	Aug 03 '26	Proposed Sale	43.87	990	43,431		Aug 03 04:48 PM
VANESSA KUBO	Officer	Aug 03 '26	Proposed Sale	43.87	23,818	1,044,896		Aug 03 04:17 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jul 28 '26	Sale	42.06	250,000	10,514,914	200,000	Jul 30 09:42 PM
Eric Lefkofsky	Officer	Jul 28 '26	Proposed Sale	42.91	250,000	10,727,500		Jul 28 04:40 PM
Fukushima Ryan	CEO, Data	Jul 08 '26	Sale	57.39	33,284	1,910,123	167,763	Jul 10 04:15 PM
VANESSA KUBO	Officer	Jul 08 '26	Proposed Sale	60.09	33,284	2,000,036		Jul 08 04:59 PM
Fukushima Ryan	CEO, Data	Jul 06 '26	Sale	60.00	10,000	600,000	201,047	Jul 08 04:15 PM
VANESSA L KUBO	Officer	Jul 06 '26	Proposed Sale	60.27	10,000	602,700		Jul 06 04:45 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 29 '26	Sale	57.48	166,250	9,556,389	8,775,283	Jul 01 04:15 PM
Doudna Jennifer A	Director	Jun 25 '26	Sale	55.00	2,673	147,015	25,942	Jun 29 08:40 PM
Rogers James William	Chief Financial Officer	Jun 25 '26	Sale	55.00	11,529	634,095	114,866	Jun 29 08:40 PM
Eric Lefkofsky	Officer	Jun 29 '26	Proposed Sale	56.14	166,250	9,333,275		Jun 29 05:52 PM
JAMES ROGERS	Officer	Jun 25 '26	Proposed Sale	51.94	11,529	598,816		Jun 25 04:25 PM
Epstein David R	Director	Jun 01 '26	Sale	49.40	250	12,350	31,464	Jun 03 04:28 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 27 '26	Sale	46.70	166,250	7,763,312	8,808,533	May 29 04:15 PM
Eric Lefkofsky	Officer	May 27 '26	Proposed Sale	46.66	166,250	7,757,225		May 27 04:45 PM
Schoenherr Thomas Edward	CEO, Diagnostics	May 19 '26	Sale	44.07	1,580	69,631	107,029	May 21 05:05 PM
Rogers James William	Chief Financial Officer	May 19 '26	Sale	44.07	10,853	478,292	126,395	May 21 05:05 PM
Polovin Andrew	EVP, Chief Legal Officer	May 19 '26	Sale	44.07	8,703	383,541	128,215	May 21 05:05 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 19 '26	Sale	44.07	22,335	984,303	2,230,721	May 21 05:05 PM
Fukushima Ryan	CEO, Data	May 19 '26	Sale	44.07	13,550	597,148	603,558	May 21 05:05 PM
Bartolucci Ryan M	Chief Accounting Officer	May 19 '26	Sale	44.07	4,116	181,392	74,041	May 21 05:05 PM
Ryan M. Bartolucci	Officer	May 19 '26	Proposed Sale	43.62	4,116	179,540		May 20 05:14 PM
James William Rogers	Officer	May 19 '26	Proposed Sale	43.62	10,853	473,408		May 20 05:13 PM
Erik Phelps	Officer	May 19 '26	Proposed Sale	43.62	6,418	279,953		May 20 05:11 PM
Thomas Edward Schoenherr	Officer	May 19 '26	Proposed Sale	43.62	1,580	68,920		May 20 05:09 PM
Andrew Polovin	Officer	May 19 '26	Proposed Sale	43.62	8,703	379,625		May 20 05:07 PM
Eric Paul Lefkofsky	Officer	May 19 '26	Proposed Sale	43.62	22,335	974,253		May 20 05:05 PM
Ryan Fukushima	Officer	May 19 '26	Proposed Sale	43.62	13,550	591,051		May 20 05:04 PM
LEFKOFSKY ERIC P	CEO and Chairman	Apr 28 '26	Sale	51.13	166,250	8,500,623	8,841,783	Apr 30 04:30 PM
Eric Lefkofsky	Officer	Apr 28 '26	Proposed Sale	52.68	166,250	8,758,050		Apr 28 04:41 PM
JENNIFER DOUDNA	Director	Apr 15 '26	Proposed Sale	49.53	3,348	165,826		Apr 15 04:39 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 26 '26	Sale	46.38	166,250	7,711,150	8,875,033	Mar 27 09:46 PM
Eric Lefkofsky	Officer	Mar 26 '26	Proposed Sale	46.76	166,250	7,773,850		Mar 26 04:27 PM
Epstein David R	Director	Mar 02 '26	Sale	50.69	250	12,672	25,801	Mar 04 04:30 PM
Rogers James William	Chief Financial Officer	Mar 02 '26	Sale	50.69	11,414	578,576	127,248	Mar 04 04:30 PM
JAMES ROGERS	Officer	Mar 02 '26	Proposed Sale	53.25	13,583	723,295		Mar 02 04:40 PM
DAVID R. EPSTEIN	Director	Mar 02 '26	Proposed Sale	53.25	870	46,328		Mar 02 04:38 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '26	Sale	58.87	166,250	9,787,605	8,908,283	Feb 20 09:45 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '26	Sale	59.05	13,587	802,312	1,989,626	Feb 20 09:45 PM
Phelps Erik	EVP, Chief Admin. Officer	Feb 19 '26	Sale	59.43	9,464	562,472	79,816	Feb 20 06:45 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '26	Sale	59.05	2,902	171,363	41,159	Feb 20 06:45 PM
Polovin Andrew	EVP, Chief Legal Officer	Feb 20 '26	Sale	60.31	10,949	660,292	126,918	Feb 20 06:45 PM
Polovin Andrew	EVP, Chief Legal Officer	Feb 19 '26	Sale	59.05	8,143	480,844	99,447	Feb 20 06:45 PM
Fukushima Ryan	Chief Executive Officer, Data	Feb 19 '26	Sale	59.05	9,592	566,408	694,354	Feb 20 06:45 PM
Rogers James William	Chief Financial Officer	Feb 19 '26	Sale	59.05	10,084	595,460	101,166	Feb 20 06:45 PM
ERIK PHELPS	Officer	Feb 20 '26	Proposed Sale	59.96	3,823	229,227		Feb 20 04:28 PM
ANDREW POLOVIN	Officer	Feb 20 '26	Proposed Sale	59.96	10,949	656,502		Feb 20 04:25 PM
Ryan M. Bartolucci	Officer	Feb 19 '26	Proposed Sale	56.16	2,902	162,976		Feb 19 09:24 PM
Andrew Polovin	Officer	Feb 19 '26	Proposed Sale	56.16	8,143	457,311		Feb 19 09:22 PM
Eric Paul Lefkofsky	Officer	Feb 19 '26	Proposed Sale	56.16	13,587	763,046		Feb 19 09:20 PM
Ryan Fukushima	Officer	Feb 19 '26	Proposed Sale	56.16	9,592	538,687		Feb 19 09:17 PM
Erik Phelps	Officer	Feb 19 '26	Proposed Sale	56.16	5,650	317,304		Feb 19 09:15 PM
James William Rogers	Officer	Feb 19 '26	Proposed Sale	56.16	10,084	566,317		Feb 19 09:13 PM
ERIK PHELPS	Officer	Feb 19 '26	Proposed Sale	56.16	3,814	214,194		Feb 19 04:43 PM
Eric Lefkofsky	Officer	Feb 19 '26	Proposed Sale	56.16	166,250	9,336,600		Feb 19 04:08 PM
Tempus AI, Inc.	10% Owner	Nov 18 '25	Buy	7.67	64,750	496,632	12,783,550	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 25 '25	Buy	10.62	23,600	250,665	12,918,346	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 22 '25	Buy	8.93	28,000	250,040	13,039,067	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 21 '25	Buy	9.40	26,499	249,190	12,869,521	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 24 '25	Buy	9.87	25,225	248,971	12,894,746	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 19 '25	Buy	8.12	30,645	248,837	12,814,195	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 20 '25	Buy	8.63	28,827	248,777	12,843,022	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 17 '25	Buy	7.86	31,650	248,769	12,949,996	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 19 '25	Buy	8.39	29,641	248,688	13,011,067	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 18 '25	Buy	7.91	31,430	248,611	12,981,426	Feb 13 05:24 PM
Epstein David R	Director	Feb 02 '26	Sale	59.41	370	21,982	26,051	Feb 04 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 28 '26	Sale	65.56	166,250	10,899,207	8,941,533	Jan 30 04:15 PM
Eric Lefkofsky	Officer	Jan 28 '26	Proposed Sale	66.81	166,250	11,107,162		Jan 28 04:21 PM
Fukushima Ryan	Chief Operating Officer	Jan 05 '26	Sale	64.26	5,000	321,300	148,808	Jan 07 06:25 PM
Doudna Jennifer A	Director	Jan 02 '26	Sale	60.17	1,250	75,212	22,702	Jan 06 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Dec 18 '25	Sale	63.99	166,250	10,638,478	8,974,783	Dec 22 05:41 PM
Eric Lefkofsky	Officer	Dec 18 '25	Proposed Sale	64.61	166,250	10,741,413		Dec 18 04:39 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 16 '25	Sale	67.42	1,302	87,781	89,280	Dec 18 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TEM

Tempus AI Inc

Upgrade your Finviz experience